emgality

Generic: galcanezumab-gnlm

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name emgality
Generic Name galcanezumab-gnlm
Labeler eli lilly and company
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

galcanezumab 120 mg/mL

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-1436
Product ID 0002-1436_36fde2df-4f86-4823-a2d5-832041e22960
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761063
Listing Expiration 2026-12-31
Marketing Start 2018-09-27

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00021436
Hyphenated Format 0002-1436

Supplemental Identifiers

RxCUI
2058872 2058877 2058885 2058887 2170611 2170613
UNII
55KHL3P693

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name emgality (source: ndc)
Generic Name galcanezumab-gnlm (source: ndc)
Application Number BLA761063 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 120 mg/mL
source: ndc
Packaging
  • 1 SYRINGE in 1 CARTON (0002-1436-11) / 1 mL in 1 SYRINGE (0002-1436-01)
  • 2 SYRINGE in 1 CARTON (0002-1436-61) / 1 mL in 1 SYRINGE
source: ndc

Packages (2)

0002-1436-11 1 SYRINGE in 1 CARTON (0002-1436-11) / 1 mL in 1 SYRINGE (0002-1436-01) 0002-1436-61 2 SYRINGE in 1 CARTON (0002-1436-61) / 1 mL in 1 SYRINGE

Ingredients (1)

galcanezumab (120 mg/mL)

Linked Drug Pages (1)

EMGALITY ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "36fde2df-4f86-4823-a2d5-832041e22960", "openfda": {"unii": ["55KHL3P693"], "rxcui": ["2058872", "2058877", "2058885", "2058887", "2170611", "2170613"], "spl_set_id": ["33a147be-233a-40e8-a55e-e40936e28db0"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (0002-1436-11)  / 1 mL in 1 SYRINGE (0002-1436-01)", "package_ndc": "0002-1436-11", "marketing_start_date": "20180927"}, {"sample": true, "description": "2 SYRINGE in 1 CARTON (0002-1436-61)  / 1 mL in 1 SYRINGE", "package_ndc": "0002-1436-61", "marketing_start_date": "20180927"}], "brand_name": "EMGALITY", "product_id": "0002-1436_36fde2df-4f86-4823-a2d5-832041e22960", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "0002-1436", "generic_name": "galcanezumab-gnlm", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EMGALITY", "active_ingredients": [{"name": "GALCANEZUMAB", "strength": "120 mg/mL"}], "application_number": "BLA761063", "marketing_category": "BLA", "marketing_start_date": "20180927", "listing_expiration_date": "20261231"}